Impact of Ischemia on cellular metabolism:Chapter 1 by Gourdin, Maximilien & Dubois, Philippe
RESEARCH OUTPUTS / RÉSULTATS DE RECHERCHE
Author(s) - Auteur(s) :
Publication date - Date de publication :
Permanent link - Permalien :
Rights / License - Licence de droit d’auteur :
Bibliothèque Universitaire Moretus Plantin
Institutional Repository - Research Portal
Dépôt Institutionnel - Portail de la Recherche
researchportal.unamur.be
Impact of Ischemia on cellular metabolism
Gourdin, Maximilien; Dubois, Philippe
Published in:
Artery Bypass
DOI:
10.5772/54509
Publication date:
2014
Document Version
Publisher's PDF, also known as Version of record
Link to publication
Citation for pulished version (HARVARD):
Gourdin, M & Dubois, P 2014, Impact of Ischemia on cellular metabolism: Chapter 1. in WS Aronow (ed.), Artery
Bypass. InTech, Croatia, pp. 3-17. https://doi.org/10.5772/54509
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 21. May. 2019
Chapter 1
Impact of Ischemia on Cellular Metabolism
Maximilien Gourdin and Philippe Dubois
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/54509
1. Introduction
As in all aerobic eukaryotic cells, oxygen is essential for homeostasis in human cells. The in‐
terruption of blood flow to tissues results in an arrested oxygen supply and disrupts the bio‐
chemical reactions that ensure the smooth functioning, integrity and survival of the cells.
The limited oxygen reserves that are dissolved in the interstitial fluid and are bound to he‐
moglobin, myoglobin and neuroglobin do not maintain efficient, long-term metabolism.[1,2]
Lack of oxygen affects all functions within the cell. Table 1 summarizes the main cellular
consequences of ischemia.
(1) cellular acidosis;
(2) loss of sarcoplasmic membrane potential;
(3) cellular swelling;
(4) cytoskeleton disorganization;
(5) reduction of adenosine-5’-triphospate (ATP)
and phosphocreatine is more than reduction in
the energy substrates;
(6) reduction of glutathione, of a-tocopherol;
(7) increasing expression of leukocyte adhesion
molecules;
(8) secretion of cytokines/chemokines
- Tumor Necrosis Factor (TNF-α)
- Interleukins (IL-) -1, 6, 8
Table 1. Major cellular consequences of ischemia
© 2013 Gourdin and Dubois; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Adenosine triphosphate depletion
Eukaryotic cells contain mitochondria, organelles whose main function is to produce adeno‐
sine triphosphate (ATP). ATP is an essential energy substrate, as its hydrolysis provides en‐
ergy for many metabolic and biochemical reactions involved in development, adaptation
and cell survival. ATP production in an aerobic cell is particularly effective when the degra‐
dation of key nutrients such as glucose and fatty acids is coupled to a supramolecular com‐
plex located in the inner membrane of mitochondria to drive oxidative phosphorylation.
Oxidative phosphorylation is mediated by an electron transport chain that consists of four
protein complexes and establishes a transmembrane electrochemical gradient by supporting
the accumulation of protons in the intermembrane space of the mitochondria. This gradient
is used as an energy source by ATP synthase during the synthesis of an ATP molecule from
a molecule of adenosine diphosphate (ADP) and an inorganic phosphate (Figure 1). Without
oxygen, oxidative phosphorylation stops: the proton gradient between the intermembrane
space and the inner mitochondria is abolished, and ATP synthesis is interrupted. The ensu‐
ing rapid fall in intracellular ATP induces a cascade of events leading to reversible cell dam‐
age. However, over time, the damage increases and gradually becomes irreversible, which
may lead to cell death and destruction of the parenchymal tissue.
Figure 1. Hydrolysis of Adenosine-triphosphate provides energy (30.5 kJ per mole) for biochemical reactions
When devoid of ATP, the cell derives its energy from the pyrophosphate bonds of ADP as
they are degraded to adenosine monophosphate (AMP) and then to adenosine. Adenosine
diffuses freely out of the cell, dramatically reducing the intracellular pool of adenine nucleo‐
tides, the precursors for ATP.
3. Changes in metabolism (Figure 2)
In the presence of oxygen, human cells respire and derive their energy from the complete
degradation of food (fats, carbohydrates and amino acids) by specific oxidative processes
that fuel oxidative phosphorylation. A lack of oxygen completely changes these metabolic
pathways, disrupting glycolysis and inhibiting the degradation pathways of lipids (beta-oxi‐
dation), amino acids and oxidative phosphorylation.
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3.1. Glucose metabolism
During ischemia, the cell will change not only its glucose supply routes but also its glycoly‐
sis pathways and transition from aerobic glycolysis to anaerobic glycolysis. When this hap‐
pens, the available cytosolic glucose is metabolized by anaerobic glycolysis and becomes the
main source of ATP. The efficiency of this process is much lower than that of aerobic glycol‐
ysis coupled to oxidative phosphorylation; the anaerobic degradation of one molecule of
glucose produces 2 ATP molecules compared to the 36 ATP molecules that are produced un‐
der aerobic conditions. Consumption quickly exceeds production, and the intracellular con‐
centration of ATP decreases. For example, in the heart, the degree of glycolysis inhibition is
directly proportional to the severity of coronary flow restriction.[3]-[5]
3.1.1. Glucose supply
With the complete interruption of or decrease in blood flow, the extracellular concentration
of glucose drops very quickly. First, the cell optimizes the uptake of glucose from the inter‐
stitial space by improving glucose transmembrane transport by increasing the sarcoplasmic
expression of the high-affinity glucose transporters GLUT-1 and GLUT-4. [6]-[8] This protec‐
tive mechanism temporarily compensates for the decrease in extracellular glucose concen‐
tration. Next, the cell uses its intracellular glucose stores of glycogen. [9] The decrease in
intracellular ATP and glucose-6-phosphate, the rising lactate/pyruvate ratio and the increase
in intracellular AMP and the inorganic phosphate concentration activate a phosphorylase
kinase, which catalyses the conversion of glycogene phosphorylase b to its active form, gly‐
cogene phosphorylase a. This cascade reaction leads to an intense and rapid consumption of
glycogen. [10]-[14]
3.1.2. Glycolysis pathways
The inhibition of oxidative phosphorylation caused by lack of oxygen does not allow the
pyruvate produced by glycolysis to be degraded. Under aerobic conditions, pyruvate is
transported into the mitochondria and feeds into the Krebs cycle, which provides the nicoti‐
namide adenine dinucleotide (NADH, H+) and flavine adenine dinucleotide (FADH2) cofac‐
tors for oxidative phosphorylation, significantly increasing the yield of glycolysis.
Ischemia modulates the activity of the following two key enzymes of anaerobic glycolysis:
phosphofructo-1-kinase (PF1K) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Following the onset of ischemia, or during moderate ischemia, the activation of glycogenol‐
ysis accelerates glycolysis.[15]-[17] The decrease in both intracellular ATP and creatine phos‐
phate, along with increases in the intracellular concentrations of AMP, inorganic phosphate
and fructose-1,6-bisphosphate, intensify the activity of PF1K and GAPDH. [17]-[20]
During prolonged or sustained ischemia, the low intracellular glucose concentration, the
disappearance of glycogen and severe intracellular acidosis eventually inhibit PF1K. Fur‐
thermore, high concentrations of lactate and protons in ischemic tissues also inhibit
GAPDH. [21],[22]
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Moreover, the lactate/pyruvate ratio, intracellular acidosis and the absence of regenerated
essential cofactors, such as NADH,H+, affect the catalytic activity of the other enzymes in‐
volved in the initial step of glycolysis and prevent the optimal performance of anaerobic
glycolysis. [23]
3.2. Lipid metabolism (Figure 2)
The importance of  oxygen in functional  oxidative phosphorylation leads to a significant
reduction in  ATP production from the beta-oxidation of  fatty  acids  that  is  proportional
to the degree of ischemia. In mild to moderate ischemia, the rate of fatty acid oxidation
decreases  but  still  fuels  oxidative phosphorylation.  [4],[24]  In  more severe ischemia,  the
lack of the cofactors NADH,H+  and FAD+,  which are normally regenerated through oxi‐
dative  phosphorylation,  completely  inhibits  acyl-CoenzymeA  (acyl-CoA)  dehydrogenase
and  3-hydroxyacyl-CoA  dehydrogenase,  which  are  key  beta-oxidation  enzymes.[4],[25]
The  cytosolic  concentrations  of  fatty  acids,  acyl-CoA  and  acylcarnitine  rise  gradually.
[26]-[28]  The accumulation of  these amphiphilic  compounds in ischemic tissues has ma‐
jor functional implications.  They dissolve readily in cell  membranes and affect the func‐
tional  properties  of  membrane  proteins.  Decreased  activity  of  Na+/K+-ATPase  and  the
sarcoplasmic and endoplasmic reticulum Ca2+-ATPase pumps, as well as the activation of
ATP-dependent  potassium  channels,  reduces  the  inwardly  rectifying  potassium  current
and prolongs the opening of Na+  channels, delaying their inactivation.[29]-[31] The accu‐
mulation of  amphiphilic  compounds produces  a  time-dependent  reversible  reduction in
gap-junction conductance. [31]
3.3. Metabolite detoxification pathways
Reducing  the  intracellular  concentration  of  ATP  inhibits  the  hexose  phosphate  cycle.
This  metabolic  pathway  regenerates  glutathione,  ascorbic  acid  and  tocopherol,  which
are  involved in  the  detoxification  of  metabolites  from the  cytosol  and the  sarcoplasmic
membrane.
4. Intracellular acidosis
Intracellular acidosis is a cardinal feature of cellular ischemia. The increased production of
protons due to metabolic modifications very quickly saturates the buffering capacity of the
cell. Intracellular acidosis interferes directly and indirectly with the optimal functioning of
the cell by increasing intracellular Na+ through the activation of Na+/H+ exchangers and by
Ca2+ activation of Na+/Ca2+ exchangers, increasing the production of free radicals; changing
the affinity of different proteins, such as enzymes and troponin C, to Ca2+; modifying terti‐
ary protein structures; inhibiting enzymes; and disrupting the function of sarcoplasmic
pumps and carriers.[29]
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dehydrogenase and 3-hydroxyacyl-CoA dehydrogenase, which are key beta-oxidation enzymes.[4],[25] The cytosolic concentrations 
of fatty acids, acyl-CoA and acylcarnitine rise gradually. [26]-[28] The accumulation of these amphiphilic compounds in ischemic 
tissues has major functional implications. They dissolve readily in cell membranes and affect the functional properties of 
membrane proteins. Decreased activity of Na+/K+-ATPase and the sarcoplasmic and endoplasmic reticulum Ca2+-ATPase pumps, as 
well as the activation of ATP-dependent potassium channels, reduces the inwardly rectifying potassium current and prolongs the 
opening of Na+ channels, delaying their inactivation.[29]-[31] The accumulation of amphiphilic compounds produces a time-
dependent reversible reduction in gap-junction conductance. [31]  
 
Figure 2. This figure shows schematically oxidative metabolism, ATP production and the consequences of oxygen deprivation. GLUT-1 and 
GLUT-4: glucose transporters; GP: Glycogene phosphorylase; HK: Hexokinase; PF1K: Phosphofructo-1-kinase; GADPH: glyceraldehyde-3-
phosphate dehydrogenase; NADH, H+: nicotinamide adenine dinucleotide; FADH2: flavine adenin dinucleotide; P: phosphate;AMP, adenosine 
monophosphate; adenosine diphosphate;ADP: adenosine diphosphate ATP: adenosine triphosphate;   CO2 : carbon dioxide; O2 Oxygen; - : 
inhibition; + activation; H+: proton; e-: electron. 
3.3. Metabolite detoxification pathways 
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Figure 2. This figure shows schematically oxidative metabolis , ATP production and the consequences of oxygen
deprivation. GLUT-1 and GLUT-4: glucose transporters; GP: Glycogene phosphorylase; HK: Hexokinase; PF1K: Phospho‐
fructo-1-kinase; GADPH: glyceraldehyde-3-phosphate dehydrogenase; NADH, H+: nicotinamide adenine dinucleotide;
FADH2: flavine adenin dinucleotide; P: phosphate;AMP, adenosine monophosphate; adenosine diphosphate;ADP: ad‐
enosine diphosphate ATP: adenosine triphosphate; CO2 : carbon dioxide; O2 Oxygen; - : inhibition; + activation; H+:
proton; e-: electron.
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The main source of protons during ischemia comes from the production of lactate from pyr‐
uvate by lactate dehydrogenase. The accumulation of extracellular lactate greatly reduces
the effectiveness of the lactate/proton cotransporter, preventing the removal of protons. Ad‐
ditionally, the residual metabolic activity also contributes to acidosis, as the hydrolysis of an
ATP molecule releases a proton.
5. Changes in the ionic cellular equilibrium (Figure 3)
Ischemia induces a profound disturbance of the ionic homeostasis of a cell. The two major
changes are the loss of ionic transmembrane gradients, which causes membrane depolariza‐
tion, and increased intracellular sodium ([Na+]i), which is responsible for inducing a rise in
the intracellular calcium ([Ca2+]i) levels, leading to cellular edema.
Cellular depolarization occurs very rapidly after the onset of ischemia, and these mecha‐
nisms are not fully understood. However, it is recognized that both the inhibition of the Na
+/K+-ATPase and the opening of ATP-dependent K+ channels play a crucial role. Cellular de‐
polarization is characterized by a negative outgoing current and a decrease in the extracellu‐
lar concentrations of Na+, Cl- and Ca2+, as well as an increase in the extracellular
concentration of K+. Progressive depolarization of the cell also promotes prolonged activa‐
tion of voltage-dependent sodium channels. [29]
The accumulation of sodium in the cytosol is multifactorial. Acidosis stimulates Na+/H+ ex‐
changers to purge cellular H+, which results in increased intracellular Na+.[32]-[34] This net
movement of Na+ is accompanied by osmotic water movement. Moreover, inhibition of the
Na+/K+-ATPase due to a lack of ATP prevents the removal of excess intracellular Na+. The
high intracellular concentration of Na+ affects the function of other membrane transporters,
such as the Na+/Ca2+ antiporter, an accelerator. This allows the extrusion of sodium from the
cell at the expense of an intracellular accumulation of Ca2+. The massive entry of calcium in‐
to the cell disrupts the mechanisms that regulate its intracellular concentration and induces
the release of calcium from the intracellular endoplasmic reticulum stores.[35] The lack of
ATP prevents calcium excretion into the interstitium and its sequestration in the endoplas‐
mic reticulum. The accumulation of cytosolic calcium induces degradation of membrane
phospholipids and cytoskeletal proteins, alters the both the calcium affinity and the efficien‐
cy of proteins involved in contractility, activates nitric oxide synthase (NOS) and proteases
such as calpains and caspases, promotes the production of free radicals and alters the terti‐
ary structure of enzymes such as xanthine dehydrogenase, which is converted to xanthine
oxidase. [36]-[38]
6. Mitochondria
The mitochondrion plays a central role in ischemic injury. Not only is it the site of critical
biochemical reactions in the cell, such as oxidative phosphorylation, beta-oxidation and the
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citric acid cycle, but it also occupies a unique position in the cellular balance between life
and death. Inhibition of the mitochondrial respiratory chain as a result of oxygen depriva‐
tion is the cornerstone of metabolic disturbances.
 
Figure 3. This figure summarizes the ionic perturbations in an ischemic cell. 
6.1. Disturbance of ATP synthesis. 
Without the respiratory chain oxidation-reduction reactions, proton accumulation in the mitochondrial intermembrane space is 
interrupted, disrupting the electrochemical gradient that allows ATP synthase to synthesize ATP. During ischemia, the proton-
translocating F0F1-ATP synthase, which normally produces ATP, becomes an F0F1-ATPase and consumes ATP in order to pump 
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primarily the superoxide anion O2-● at complexes I and III of the electron transport chain. The anion is rapidly converted to 
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Figure 3. This figure summarizes the ionic perturbations in an ischemic cell.
6.1. Disturbance of ATP synthesis.
Without the respiratory chain xidation-reduction reaction , proton accumulation in the mi‐
tochondrial intermembrane space is interrupted, disrupting the electrochemical gradient
that allows ATP synthase to synthesize ATP. During ischemia, the proton-translocating
F0F1-ATP synthase, which normally produces ATP, becomes an F0F1-ATPase and con‐
sumes ATP in order to pump protons from the matrix to the intermembrane space and
maintain the mitochondrial membrane potential.[39],[40] The mitochondria therefore be‐
come a site of ATP consumption produced by anaerobic glycolysis.
6.2. An incre se in free radical productio
Free ra ical oxygen species (ROS) are highly eactive chemical compounds because they
have unpaired electrons in their electron cloud. ROS are capable of oxidizing cellular con‐
stituents such as proteins, deoxyribonucleic acid (DNA), membrane phospholipids and oth‐
er adjacent biological structures. In addition to their role in ischemia, ROS are constitutively
generated during metabolic processes and have an important role in cell signaling. Mito‐
chondrial respiration constitutively produces a small amount of ROS, primarily the superox‐
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ide anion O2-● at complexes I and III of the electron transport chain. The anion is rapidly
converted to hydrogen peroxide (H2O2) by metallo-enzymes and superoxide dismutase
(SOD). [41]-[43] Cellular stress, particularly oxidative stress, dramatically increases mito‐
chondrial ROS production by disrupting and later inhibiting oxidative phosphorylation.
Moreover, the rise in mitochondrial calcium increases ROS production and greatly decreases
the antioxidant capacity of mitochondria by decreasing the glutathione peroxidase concen‐
tration and SOD activity.
6.3. Intramitochondrial calcium overload
The mitochondrial calcium concentration is in equilibrium between its cytosolic concentra‐
tion and the proton gradient on either side of the inner membrane of mitochondria. The loss
of this gradient due to the inhibition of the respiratory chain, as well as the elevated cytosol‐
ic calcium that results from ischemia, allows for the accumulation of calcium in the mito‐
chondria and promotes mitochondrial swelling and the opening of the permeability
transition pore.
6.4. Opening of the mitochondrial permeability transition pore
Ischemic disturbances within mitochondria, such as calcium overload, loss of membrane po‐
tential, oxidative stress, mass production of free radicals, low NADPH/NADP+ and reduced
glutathione to oxidized glutathione ratios (GSH/GSSG), low intra-mitochondrial concentra‐
tion of ATP or high inorganic phosphate, will promote opening of the permeability transi‐
tion pore (mPTP) upon reperfusion, a major player in I/R injury-mediated cell lethality.[42],
[44] mPTP is a nonspecific channel, and its opening suddenly increases the permeability of
the inner mitochondrial membrane to both water and various molecules of high molecular
weight (> 1,500 kDa). The opening of mPTPs abolishes the mitochondrial membrane poten‐
tial and uncouples oxidative phosphorylation, which empties the mitochondria of its matrix
and induces apoptosis by releasing the intra-mitochondrial proteins cytochrome c, endonu‐
clease G, Smac/Diablo and apoptosis-inducing factor into the cytosol. [44]-[52]
7. Structural and functional modifications
The cytoskeleton, the internal structural organization of a cell, is composed of a highly regu‐
lated complex network of organized structural proteins, including actin, microtubules and
lamins. The cytoskeleton performs multiple functions. It maintains internal cellular com‐
partmentalization and mediates the transmission of mechanical forces within the cell to ad‐
jacent cells and the extracellular matrix, the distribution of organelles, the movement of
molecules or components and the docking of proteins such as membrane receptors or ion
channels. Ischemia deconstructs the cytoskeleton. [53]-[56] The high intracellular concentra‐
tions of Ca2+ that are associated with ischemia activate multiple phosphorylases and proteas‐
es that disassemble and degrade the cytoskeleton, thereby eliminating the functions that rely
on its integrity, such as phagocytosis, exocytosis, myofilament contraction, intercellular
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communication and cell anchorage. Destruction of the internal architecture worsens I/R inju‐
ries and leads to apoptosis. [53],[56],[57] During ischemia, all elements of the cytoskeleton
are affected, but with different kinetics.[54],[55] Moreover, the accumulation of osmotically
active particles, including lactate, sodium, inorganic phosphate and creatine, induces cellu‐
lar oedema.[38]
Regulatory cellular mechanisms provide intracellular homeostasis that enables optimal en‐
zyme function in a relatively narrow range of environmental conditions. The conditions cre‐
ated by ischemia, such as acidosis and calcium overload, modify or inhibit the activity of
many enzymes due to changes in the pH and tertiary structures, affecting cellular metabo‐
lism. For example, ischemia induces the conversion of xanthine dehydrogenase to xanthine
oxidase.[36]-[38] These two enzymes catalyze the same reactions, converting hypoxanthine
to xanthine and xanthine to uric acid. The first reaction uses NAD+ as a cofactor, whereas the
second uses oxygen and produces O2-●, a free radical.
8. Protein synthesis and sarcoplasmic protein expression in an ischemic
cell
Protein synthesis is a complex process that requires continuous and adequate energy intake,
strict control of ionic homeostasis of the cell and the smooth functioning of many other pro‐
teins. Ischemia disrupts these necessary conditions and therefore profoundly affects protein
synthesis beyond acute injury. However, the transcription of several genes is initiated at the
onset of ischemia, and the mechanisms underlying this phenomenon are not fully under‐
stood. Nevertheless, it appears that the mass production of free radicals, the high concentra‐
tion of calcium, acidosis and the activation of the family of mitogen-activated protein
kinases (MAP kinases) play an important role. Nuclear factor heat shock transcription fac‐
tor-1 (HSF-1) activates the expression of heat shock proteins (HSPs), a family of chaperone
proteins, and inhibits the expression of other proteins. HSPs are synthesized in different sit‐
uations of stress, including hyperthermia, ischemia, hypoxia and mechanical stress, and are
intended to prevent the structural modifications of key metabolic and cytoskeletal enzymes
and inhibit the activity of caspases. [58]-[60]
The low oxygen partial pressure during ischemia activates other nuclear factors, such as hy‐
poxia-inducible factor-1alpha (HIF-1α). HIF-1α stimulates the transcription of many genes
involved in cellular defense, such as those encoding NOS and GLUT-1, and other enzymes
involved in glucose metabolism.[61]
In addition, ischemia activates innate immunity by stimulating sarcoplasmic receptors, such
as the Toll-like receptors (TLR) TLR-2 and TLR-6, the synthesis and sarcoplasmic expression
of which are increased. Receptor stimulation supports the synthesis of chemokines and cyto‐
kines and contributes to I/R injury.[61]-[66]
At the onset of ischemia, many substances are secreted by the cell. For example, ischemic
cardiomyocytes secrete bradykinin, norepinephrine, angiotensin, adenosine, acetylcholine
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and opioids.[67]-[69] In addition, ischemia stimulates the expression of adhesion molecules,
such as P-selectins, L-selectins, intercellular adhesion molecule-1 (ICAM-1) and platelet-en‐
dothelial cell adhesion molecules (PECAM), on the surface of endothelial cells, leukocytes
and other ischemic cells. [62],[63],[70],[71] Furthermore, many cytokines, such as tumor ne‐
crosis factor-α, interleukin (IL)-1, IL-6 and IL-8, and vasoactive agents, such as endothelins
and thromboxane A2, are secreted by cells in response to ischemia. [62],[70],[72] Cytokines
and chemokines, the production of which dramatically increases during reperfusion, initiate
the local inflammatory response and prepare for the recruitment of inflammatory cells into
the injured area, respectively.
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